which appeared to be more effective than anti-CD3 monoclonal antibody. To detect/enrich IFN-γ–secreting cells, cells were labeled with antibody against IFN-γ/CD45 conjugates (human assay ...

Peripheral blood CD4 + /CD8 + ratios at 12 and 24 weeks may serve as predictive markers for HBsAg clearance in IHCs treated with peg-IFN-α.

This study aimed to investigate the dynamics of peripheral blood T lymphocyte subsets during peginterferon alpha (peg-IFN-α) therapy and their association with hepatitis B surface antigen (HBsAg ...

Tiziana Life Sciences announces discovery of new immune biomarkers in multiple sclerosis patients treated with nasal foralumab: New York Friday, January 24, 2025, 17:00 Hrs [IST] ...